Mylan scores FDA approval of generic Suboxone for opioid addiction, but a strong launch is no sure bet
admin 15th June 2018 Uncategorised 0Just one day after the FDA warned Mylan it would issue a second thumbs-down on its generic asthma drug Advair, the agency granted the company one of two approvals of the first generic version of sublingual Suboxone. But competition and legal holdups threaten to stifle the launch.
More: Mylan scores FDA approval of generic Suboxone for opioid addiction, but a strong launch is no sure bet
Source: fierce